In this episode, Rick Eiswirth, president and
CEO of Alimera Sciences, shares the latest on the phase 4 New Day
study of Iluvien, as well as his predictions for the future of
ophthalmology.
Intro :13
In this episode :18
About Rick Eiswirth :23
What’s your background? How did you get into the ophthalmology
industry?...
In this podcast, Joshua Mali, MD, brings you the best insights and perspectives in the field of eye care today. Through interviews with thought leaders in ophthalmology, Mali gets the inside of every story.